Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	is ministerial correction true false answering member printed
creator	label
publisher	pref label
tabling member	label

Search

1124901

	human indexable
	published
	registered interest
	answer date	21/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 20:49:48
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 20:57:06 17/05/2019 11:39:05
	hansard heading	Nusinersen
	house id	2
	identifier	HL15576
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	17/05/2019 11:07:46
	question text	To ask Her Majesty's Government what discussions they have had with (1) NICE, (2) NHS England, and (3) Biogen, on a Managed Access Agreement for Spinal Muscular Atrophy treatment, Spinraza.
	session	2017/19
	session number	1
	tabling member printed	Baroness Thomas of Winchester
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15576
	type	WrittenParliamentaryQuestion
	uin	HL15576
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Baroness Blackwood of North Oxford
	creator	3785 label Biography information for Baroness Thomas of Winchester
	publisher	25277 pref label House of Lords
	tabling member	3785 label Biography information for Baroness Thomas of Winchester

1124902

	human indexable
	published
	registered interest
	answer date	21/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 20:49:49
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 20:57:08 17/05/2019 11:39:03
	hansard heading	National Institute for Health and Care Excellence
	house id	2
	identifier	HL15577
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	17/05/2019 11:07:46
	question text	To ask Her Majesty's Government when they estimate that NICE will publish the outcome of the NICE Evaluation Committee meeting held on 6 March.
	session	2017/19
	session number	1
	tabling member printed	Baroness Thomas of Winchester
	title	House of Lords Tabled Parliamentary Question 2017/19 HL15577
	type	WrittenParliamentaryQuestion
	uin	HL15577
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Baroness Blackwood of North Oxford
	creator	3785 label Biography information for Baroness Thomas of Winchester
	publisher	25277 pref label House of Lords
	tabling member	3785 label Biography information for Baroness Thomas of Winchester

1124720

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	03/05/2019
	date tabled	03/05/2019
	ddp created	03/05/2019 14:10:32
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	03/05/2019 14:16:34 15/05/2019 17:07:01
	hansard heading	Idiopathic Pulmonary Fibrosis
	house id	1
	identifier	250788
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:35:47
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to improve (a) early diagnosis and (b) treatment of idiopathic pulmonary fibrosis.
	session	2017/19
	session number	1
	tabling member constituency	Stevenage
	tabling member printed	Stephen McPartland
	title	House of Commons Tabled Parliamentary Question 2017/19 250788
	type	WrittenParliamentaryQuestion
	uin	250788
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	4093 label Biography information for Stephen McPartland
	publisher	25259 pref label House of Commons
	tabling member	4093 label Biography information for Stephen McPartland

1124918

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 21:09:22
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 21:15:42 15/05/2019 16:46:06
	hansard heading	Haemophilia: Medical Treatments
	house id	1
	identifier	251321
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:14:44
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that haemophilia patients receive (a) appropriate access to physiotherapy, (b) a regular clinical review, and (c) tailored dosing of treatments in accordance with NHS England’s service specification.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 251321
	type	WrittenParliamentaryQuestion
	uin	251321
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1124919

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 21:09:25
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 21:15:45 15/05/2019 16:46:04
	hansard heading	Haemophilia: Medical Treatments
	house id	1
	identifier	251322
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:14:44
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the Commercial Medicines Unit’s national tender framework for factor VIII haemophilia products on patient access to extended half-life medicines.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 251322
	type	WrittenParliamentaryQuestion
	uin	251322
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1124920

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 21:09:29
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 21:15:49 15/05/2019 16:46:03
	hansard heading	Blood Diseases: Medical Treatments
	house id	1
	identifier	251323
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:14:44
	question text	To ask the Secretary of State for Health and Social Care, what steps he NHS England is taking to ensure that patients with bleeding disorders have adequate access to treatment options that meet individual patient need.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 251323
	type	WrittenParliamentaryQuestion
	uin	251323
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1124921

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 21:09:32
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 21:15:53 15/05/2019 16:46:01
	hansard heading	Haemophilia: Medical Treatments
	house id	1
	identifier	251324
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:14:44
	question text	To ask the Secretary of State for Health and Social Care, whether NHS England has made an assessment of the adequacy of the availability of Haemtrack in Haemophilia centres.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 251324
	type	WrittenParliamentaryQuestion
	uin	251324
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1124923

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 21:09:38
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 21:15:59 15/05/2019 16:56:01
	hansard heading	Hospitals: Infectious Diseases
	house id	1
	identifier	251326
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:24:36
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 March 2019 to Question 231466 on Hospitals: Infectious Diseases, whether work of Public Health England will also include as assessment of the effect of changes to ophthalmic surgical practice on trends in the level of risk of infection rates in hospitals.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 251326
	type	WrittenParliamentaryQuestion
	uin	251326
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1124924

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 21:09:41
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 21:16:04 15/05/2019 17:15:02
	hansard heading	Ophthalmic Services
	house id	1
	identifier	251327
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:43:32
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 March 2019 to Question 231467 on Ophthalmic Services, whether he has made an assessment of the ability for clinicians to take into account patients’ wishes for concomitant treatment in relation to potential restrictions of the 2019/2020 NHS Tariff.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 251327
	type	WrittenParliamentaryQuestion
	uin	251327
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	4131 label Biography information for Jim Shannon
	publisher	25259 pref label House of Commons
	tabling member	4131 label Biography information for Jim Shannon

1124938

	human indexable
	published
	registered interest
	answer date	09/05/2019
	date	07/05/2019
	date tabled	07/05/2019
	ddp created	07/05/2019 21:10:25
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	07/05/2019 21:16:55 15/05/2019 17:01:02
	hansard heading	Health Education: Air Pollution
	house id	1
	identifier	251250
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	15/05/2019 16:30:01
	question text	To ask the Secretary of State for Health and Social Care, what progress his Department is making on producing a public information campaign to educate the general public on the health impacts of air pollution, particularly in instances of moderate or high pollution episodes.
	session	2017/19
	session number	1
	tabling member constituency	Penistone and Stocksbridge
	tabling member printed	Angela Smith
	title	House of Commons Tabled Parliamentary Question 2017/19 251250
	type	WrittenParliamentaryQuestion
	uin	251250
	version	1
	written parliamentary question type	Ordinary
	answer	answer is ministerial correction answering member printed Seema Kennedy
	creator	1564 label Biography information for Angela Smith
	publisher	25259 pref label House of Commons
	tabling member	1564 label Biography information for Angela Smith